In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan

Increasing carbapenem resistance rates worldwide underscored the urgent need of novel antimicrobials. Ceftazidime–avibactam and aztreonam–avibactam combinations are developed to combat carbapenem resistance, but biological and geographic variations must be considered for antibiotic susceptibility pa...

Descripción completa

Detalles Bibliográficos

Autores principales:	Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan-Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Yu-Tzu Lin, Sheng-Fan Wang, Sung-Pin Tseng, Po-Liang Lu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-12-01
Colección:	Microorganisms
Materias:	CR Enterobacteriaceae combination therapy molecular epidemiology of antimicrobial resistance
Acceso en línea:	https://www.mdpi.com/2076-2607/8/12/1981
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!